Analyst Research: Alexion Pharmaceuticals, Inc. (ALXN.O)
ALXN.O on Consolidated Issue listed on NASDAQ Global Market
48.26USD
1:45pm EST
48.26USD
1:45pm EST
Price Change (% chg)
$-0.18 (-0.37%)
$-0.18 (-0.37%)
Prev Close
$48.44
$48.44
Open
$48.79
$48.79
Day's High
$48.79
$48.79
Day's Low
$48.15
$48.15
Volume
90,846
90,846
Avg. Vol
357,441
357,441
52-wk High
$48.93
$48.93
52-wk Low
$30.78
$30.78
| Name | Age | Since | Current Position |
|---|---|---|---|
| Link, Max | 68 | 2002 | Chairman of the Board |
| Bell, Leonard | 51 | 2002 | Chief Executive Officer, Secretary, Treasurer, Director |
| Sinha, Vikas | 45 | 2005 | Chief Financial Officer, Senior Vice President |
| Squinto, Stephen | 52 | 2007 | Executive Vice President, Head - Research and Development |
| Rother, Russell | 48 | 2008 | Senior Vice President, Chief Scientific Officer |
- UPDATE 1-Alexion manufacturing unit gets positive CHMP opinion
- BEFORE THE BELL-Alexion shares rise after results, outlook
- UPDATE 2-Alexion Q3 results beat Street, raises FY view
- CORRECTED - CORRECTED-UPDATE 1-Alexion Q3 results beat Street, raises FY vie
- International Biotech waiting for market to retrace
© Copyright 2009 Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
